Does ALTEPLASE Cause Cerebral infarction? 202 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Cerebral infarction have been filed in association with ALTEPLASE (Activase). This represents 1.6% of all adverse event reports for ALTEPLASE.
202
Reports of Cerebral infarction with ALTEPLASE
1.6%
of all ALTEPLASE reports
69
Deaths
52
Hospitalizations
How Dangerous Is Cerebral infarction From ALTEPLASE?
Of the 202 reports, 69 (34.2%) resulted in death, 52 (25.7%) required hospitalization, and 21 (10.4%) were considered life-threatening.
Is Cerebral infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALTEPLASE. However, 202 reports have been filed with the FAERS database.
What Other Side Effects Does ALTEPLASE Cause?
No adverse event (2,456)
Off label use (1,752)
Gingival bleeding (1,018)
Cerebral haemorrhage (819)
Death (818)
Haemorrhage intracranial (615)
Angioedema (603)
Haemorrhage (536)
Drug ineffective (524)
Haemorrhagic transformation stroke (496)
What Other Drugs Cause Cerebral infarction?
RIVAROXABAN (1,367)
APIXABAN (937)
DABIGATRAN ETEXILATE (713)
ASPIRIN (535)
EDOXABAN (419)
CLOPIDOGREL BISULFATE (315)
PEMBROLIZUMAB (295)
BEVACIZUMAB (269)
METHOTREXATE (265)
NIVOLUMAB (262)
Which ALTEPLASE Alternatives Have Lower Cerebral infarction Risk?
ALTEPLASE vs ALTERNARIA ALTERNATA
ALTEPLASE vs ALTHIAZIDE
ALTEPLASE vs ALTHIAZIDE\SPIRONOLACTONE
ALTEPLASE vs ALUMINUM
ALTEPLASE vs ALUMINUM HYDROXIDE